18F-FDG PET/MRI-based liver and bone marrow organomics combined with systemic inflammatory response for predicting pathological complete response after neoadjuvant therapy in breast cancer.
OBJECTIVE To evaluate the role of liver and bone marrow organomics features derived from staging 18F-fluorodeoxyglucose (18F-FDG) PET/MRI in predicting pathological complete response (pCR) in breast cancer patients who underwent surgery after neoadjuvant therapy. METHODS In this retrospective study, breast cancer pat...